IDH’s proposed revised Delisting Buyback Price in connection with delisting from the Egyptian Exchange
(Cairo and London) — Integrated Diagnostics Holdings plc (“IDH”, the “Company” or the “Group”), a leading consumer healthcare company operating in Egypt, Jordan, Sudan, Nigeria, and Saudi Arabia, announces that on 24 May 2024, it published a Notice of the Extraordinary General Meeting (the “EGM”) to be held on 12 June 2024. This meeting was called to discuss the proposed voluntary delisting of its ordinary shares (the “Shares”) from the Egyptian Exchange (the “EGX”). As announced on 12 June 2024, all the resolutions contained in the Notice of EGM were duly passed at the meeting.